GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Gentium Spa (GENTY) [hlAlert]

Gentium S.p.A. is a biopharmaceutical company focused on the development and manufacture of defibrotide, a deoxyribonucleic acid (DNA) based drug derived from pig intestines, to treat and prevent a disease called hepatic veno-occlusive disease (VOD), a condition in which some of the veins in
the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation treatments that are given prior to stem cell transplantation. The Company is concluding a Phase III clinical trial of defibrotide to treat severe VOD in the United States, Canada and Israel. The Company is also conducting a Phase II/III clinical trial of defibrotide in Europe to prevent VOD in children. In addition to defibrotide, the Company sells urokinase, calcium heparin, sodium heparin and sulglicotide, which are active pharmaceutical ingredients used to make other drugs.
.
( Total: 4 Current Stock Recommendations )
Gentium Spa   (4)
Hold 25% Buy 75%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy GENTY
up 503.87 %

Rating:
Buy GENTY
up 503.87 %

Rating:
Hold GENTY
Gentium Spa (GENT) rated Mkt Perform by Rodman & Renshaw
Friday,  Jun 6, 2008  10:25 AM ET

Rating:
Buy GENTY
up 135.71 %

Rating:
Buy GENTY
up 186.80 %
Gentium Spa (GENT) rated Buy
Tuesday,  Aug 21, 2007  9:25 AM ET

Rating:
Buy GENTY
up 135.71 %
Gentium Spa (GENT) rated Buy
Friday,  Sep 21, 2007  9:25 AM ET

Your Recent Stocks
SymbolLastChange
GENTY 56.10 down  -0.08 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy